Skip to main content
David Alland, MD, Infectious Disease, Newark, NJ

David Alland MD

Infectious Disease•Newark, NJ

Professor, Medicine, UMDNJ-New Jersey Medical School

Join to View Full Profile

  • 150 Bergen StNewark, NJ 07103

  • Phone+1 973-972-2179

  • Fax+1 973-972-6804

Dr. Alland is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Alland's Full ProfileAlready have an account?

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 1988 - 1992
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1984 - 1987
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1984

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2001 - 2025
  • VA State Medical License
    VA State Medical License 2017 - 2020
  • FL State Medical License
    FL State Medical License 2017 - 2019
  • TX State Medical License
    TX State Medical License 2017 - 2018
  • NY State Medical License
    NY State Medical License 1986 - 2003
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Journal Articles

  • Bacterial Factors That Predict Relapse After Tuberculosis Therapy  
    David Alland, MD, The New England Journal of Medicine
  • Bacterial Factors That Predict Relapse After Tuberculosis Therapy  
    David Alland, W Henry Boom, The New England Journal of Medicine

Press Mentions

  • Pfizer, Moderna Shots Safe During in Vitro Fertilization; Healthy Gut Bacteria May Help Prevent Long COVID
    Pfizer, Moderna Shots Safe During in Vitro Fertilization; Healthy Gut Bacteria May Help Prevent Long COVIDJanuary 27th, 2022
  • This New Testing Kit Can Detect Any COVID-19 Variant in Minutes
    This New Testing Kit Can Detect Any COVID-19 Variant in MinutesJanuary 27th, 2022
  • Pfizer, Moderna Draws Safely During in Vitro Fertilization; Healthy Gut Bacteria May Help Prevent Long COVID
    Pfizer, Moderna Draws Safely During in Vitro Fertilization; Healthy Gut Bacteria May Help Prevent Long COVIDJanuary 26th, 2022
  • Join now to see all

Grant Support

  • Point of care detection of fluroquinolone, bedaquiline and linezolid resistant Mycobacterium tuberculosis for rapid treatment decisions.RUTGERS BIOMEDICAL AND HEALTH SCIENCES2024–2028
  • Point of care detection of fluroquinolone, bedaquiline and linezolid resistant Mycobacterium tuberculosis for rapid treatment decisions.RUTGERS BIOMEDICAL AND HEALTH SCIENCES2024–2028
  • Resources, Workforce Development, and Animal Models for the Rutgers RBLRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Resources, Workforce Development, and Animal Models for the Rutgers RBLRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Resources, Workforce Development, and Animal Models for the Rutgers RBLRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Resources, Workforce Development, and Animal Models for the Rutgers RBLRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Nanoreactor beads for POC TB resistance testingRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Resources, Workforce Development, and Animal Models for the Rutgers RBLRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Resources, Workforce Development, and Animal Models for the Rutgers RBLRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Resources, Workforce Development, and Animal Models for the Rutgers RBLRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Resources, Workforce Development, and Animal Models for the Rutgers RBLRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Bacterial and Host Heterogeneity in TB latency, persistence and progressionRUTGERS BIOMEDICAL AND HEALTH SCIENCES2021–2026
  • Bacterial and Host Heterogeneity in TB latency, persistence and progressionRUTGERS BIOMEDICAL AND HEALTH SCIENCES2021–2026
  • Bacterial and Host Heterogeneity in TB latency, persistence and progressionRUTGERS BIOMEDICAL AND HEALTH SCIENCES2021–2026
  • Bacterial and Host Heterogeneity in TB latency, persistence and progressionRUTGERS BIOMEDICAL AND HEALTH SCIENCES2021–2026
  • Bacterial and Host Heterogeneity in TB latency, persistence and progressionRUTGERS BIOMEDICAL AND HEALTH SCIENCES2021–2026
  • Bacterial and Host Heterogeneity in TB latency, persistence and progressionRUTGERS BIOMEDICAL AND HEALTH SCIENCES2021–2026
  • Bacterial and Host Heterogeneity in TB latency, persistence and progressionRUTGERS BIOMEDICAL AND HEALTH SCIENCES2021–2026
  • Bacterial and Host Heterogeneity in TB latency, persistence and progressionRUTGERS BIOMEDICAL AND HEALTH SCIENCES2021–2026
  • Bacteria and Host in TB TransmissionRUTGERS BIOMEDICAL AND HEALTH SCIENCES2020–2026
  • FEND for TBRUTGERS BIOMEDICAL AND HEALTH SCIENCES2020–2025
  • Novel and Optimized Diagnostics for Pediatric TBRUTGERS BIOMEDICAL AND HEALTH SCIENCES2020–2025
  • FEND for TBRUTGERS BIOMEDICAL AND HEALTH SCIENCES2020–2025
  • FEND for TBRUTGERS BIOMEDICAL AND HEALTH SCIENCES2020–2025
  • FEND for TBRUTGERS BIOMEDICAL AND HEALTH SCIENCES2020–2025
  • Genetic, Metabolic and Regulatory Control of MIC and Relapse in M. tuberculosisUNIVERSITY OF WASHINGTON2020–2025
  • FEND for TBRUTGERS BIOMEDICAL AND HEALTH SCIENCES2020–2025
  • Simple and rapid POC detection for fungemiaRUTGERS BIOMEDICAL AND HEALTH SCIENCES2020–2025
  • FEND for TBRUTGERS BIOMEDICAL AND HEALTH SCIENCES2020–2025
  • FEND for TBRUTGERS BIOMEDICAL AND HEALTH SCIENCES2020–2025
  • FEND for TBRUTGERS BIOMEDICAL AND HEALTH SCIENCES2020–2025
  • Identifying Optimal Treatment Strategies for Tuberculosis TreatmentUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2019–2024
  • On Demand Blood Tests For Select Agent DiagnosisNational Institute Of Allergy And Infectious Diseases2012
  • Development Of A Second Generation Mdr-Xdr TB AssayNational Institute Of Allergy And Infectious Diseases2009–2012
  • Rapid Diagnosis Of XDR TuberculosisNational Institute Of Allergy And Infectious Diseases2009–2011
  • Development Of A Molecular Blood CultureNational Institute Of Allergy And Infectious Diseases2009–2010
  • Afb Smears For Drug Resistance Detection And Surveillance In MTB.National Institute Of Allergy And Infectious Diseases2009–2010
  • Integrated Dual-Use Systems For Bio-Defense &Sepsis DiagnosisNational Institute Of Allergy And Infectious Diseases2007–2010
  • Sample Processing Cartridges For Rapid PCR TB DetectionNational Institute Of Allergy And Infectious Diseases2006–2008
  • Detection Of Select Agents In Single-Well AssaysNational Institute Of Allergy And Infectious Diseases2003–2007
  • Towards Drugs That Prevent Resistance To The HIV Oi, TBNational Institute Of Allergy And Infectious Diseases2005–2006
  • Tuberculosis Genotyping And Evolutionary ConsortiumNational Institute Of Allergy And Infectious Diseases2002–2005
  • Population Based Investigations Of TuberculosisNational Institute Of Allergy And Infectious Diseases2001–2004
  • Sample Processing Cartridges For Rapid PCR TB DetectionNational Institute Of Allergy And Infectious Diseases2002
  • Population Based Investigations Of TuberculosisNational Institute Of Allergy And Infectious Diseases2000–2001
  • Tuberculosis Curriculum For An Urban Medical CenterNational Heart, Lung, And Blood Institute1997–2000

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. David Alland, Dr. David Alland, MD, Dr. D Alland